Dr Mukesh Kumar, Chief Scientific Officer, CLINEXEL
Biopharma Leadership & Innovation Conclave 2025 | 8th October 2025 | Pune
Speaker in this video:
Dr Mukesh Kumar, Chief Scientific Officer, CLINEXEL
Topic: Efficient clinical development strategies for innovative products: Focus on emerging biotech
Key Highlights:
[1] Emerging biotech companies should adopt lean and adaptive clinical development strategies—focusing on efficient trial designs, smart use of real-world evidence, and prioritizing speed without compromising scientific rigor.
[2] Collaborations with CROs, academic institutions, and global networks can provide critical expertise, infrastructure, and regulatory support, helping smaller companies scale their clinical programs effectively.
[3] Engaging with regulators early in the development journey and aligning clinical plans with market access strategies can significantly reduce risks, optimize resources, and improve the probability of successful product launches.